{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:02:58Z","timestamp":1761102178939},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.peptides.2016.01.005","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T00:36:07Z","timestamp":1452645367000},"page":"87-95","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Application of synthetic peptides for detection of anti-citrullinated peptide antibodies"],"prefix":"10.1016","volume":"76","author":[{"given":"Nicole Hartwig","family":"Trier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina Eide","family":"Holm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole","family":"Slot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Locht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Lindegaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoffer Tandrup","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Theander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Houen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2016.01.005_bib0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","article-title":"Epidemiology of adult rheumatoid arthritis","volume":"4","author":"Alamanos","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.peptides.2016.01.005_bib0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/ar395","article-title":"Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value","volume":"4","author":"van Boekel","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.peptides.2016.01.005_bib0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.autrev.2009.11.017","article-title":"Profiling of rheumatoid arthritis associated autoantibodies","volume":"9","author":"Conrad","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.peptides.2016.01.005_bib0020","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","article-title":"Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis","volume":"64","author":"Nell","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.peptides.2016.01.005_bib0025","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar551","article-title":"Autoantibodies in rheumatoid arthritis and their clinical significance","volume":"4","author":"Steiner","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.peptides.2016.01.005_bib0030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","article-title":"The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro) filaggrin by deimination of arginine residues","volume":"162","author":"Girbal-Neuhauser","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.peptides.2016.01.005_bib0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2016.01.005_bib0040","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2016.01.005_bib0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000237386","article-title":"Autoantibodies to the A\/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases","volume":"111","author":"Steiner","year":"1996","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.peptides.2016.01.005_bib0050","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.peptides.2016.01.005_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar1027","article-title":"Citrullination, a possible functional link between susceptibility genes and rheumatoid arthritis","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.peptides.2016.01.005_bib0060","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.37835","article-title":"Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis","volume":"65","author":"Brink","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.peptides.2016.01.005_bib0065","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/ard.2004.029389","article-title":"Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis","volume":"64","author":"Nielen","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.peptides.2016.01.005_bib0070","doi-asserted-by":"crossref","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2016.01.005_bib0075","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.30537","article-title":"Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis","volume":"63","author":"van de Stadt","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.peptides.2016.01.005_bib0080","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/ard.2009.124537","article-title":"Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis","volume":"69","author":"van der Woude","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.peptides.2016.01.005_bib0085","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/art.24716","volume":"60","author":"van der Linden","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.peptides.2016.01.005_bib0090","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/art.22597","article-title":"Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark","volume":"56","author":"Pedersen","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.peptides.2016.01.005_bib0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.smim.2011.01.014","article-title":"Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis","volume":"23","author":"Klareskog","year":"2005","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.peptides.2016.01.005_bib0100","doi-asserted-by":"crossref","DOI":"10.1007\/s00784-015-1556-7","article-title":"Citrullination in the periodontium-a possible link between periodontitis and rheumatoid arthritis","author":"Laugisch","year":"2016","journal-title":"Clin. Oral Investig."},{"key":"10.1016\/j.peptides.2016.01.005_bib0105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrrheum.2010.139","article-title":"Periodontitis in RA-the citrullinated enolase connection","volume":"6","author":"Lundberg","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.peptides.2016.01.005_bib0110","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/art.27552","article-title":"Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis","volume":"62","author":"Wegner","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.peptides.2016.01.005_bib0115","first-page":"647","article-title":"Antibodies to viral citrullinated peptide in rheumatoid arthritis","volume":"33","author":"Anzilotti","year":"2006","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.peptides.2016.01.005_bib0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1196\/annals.1313.025","article-title":"A deiminated viral peptide to detect antibodies in rheumatoid arthritis","volume":"1050","author":"Merlini","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.peptides.2016.01.005_bib0125","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/art.21629","article-title":"Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"54","author":"Pratesi","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.peptides.2016.01.005_bib0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2249.2011.04378.x","article-title":"Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies","volume":"164","author":"Pratesi","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.peptides.2016.01.005_bib0135","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/eji.200526000","article-title":"Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis","volume":"35","author":"Burkhardt","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.peptides.2016.01.005_bib0140","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","article-title":"Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis","volume":"7","author":"Kinloch","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.peptides.2016.01.005_bib0145","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/ard.2005.044743","article-title":"Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids","volume":"65","author":"Takizawa","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.peptides.2016.01.005_bib0150","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","article-title":"Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.peptides.2016.01.005_bib0155","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/eji.200535790","article-title":"Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins","volume":"36","author":"Sebbag","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.peptides.2016.01.005_bib0160","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/pro.2178","article-title":"Cross-reactivity of a human IgG(1) anticitrullinated fibrinogen monoclonal antibody to a citrullinated profilaggrin peptide","volume":"21","author":"Trier","year":"2012","journal-title":"Protein Sci."},{"key":"10.1016\/j.peptides.2016.01.005_bib0165","first-page":"472174","article-title":"Isotypes of Epstein-Barr virus antibodies in rheumatoid arthritis: association with rheumatoid factors and citrulline-dependent antibodies","author":"Westergaard","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.peptides.2016.01.005_bib0170","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2249.2004.02704.x","volume":"139","author":"Yamazaki","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.peptides.2016.01.005_bib0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.peptides.2016.01.005_bib0180","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.peptides.2016.01.005_bib0185","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.peptides.2016.01.005_bib0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.peptides.2016.01.005_bib0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jneuroim.2011.12.020","article-title":"Identification of continuous epitopes of HuD antibodies related to paraneoplastic diseases\/small cell lung cancer","volume":"243","author":"Trier","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.peptides.2016.01.005_bib0200","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/rheumatology\/kem193","article-title":"IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders","volume":"46","author":"Anzilotti","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.peptides.2016.01.005_bib0205","first-page":"5872","article-title":"Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface","volume":"53","author":"Lubin","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.peptides.2016.01.005_bib0210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2249.2003.02246.x","article-title":"Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies","volume":"134","author":"Staikou","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.peptides.2016.01.005_bib0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejphar.2012.04.025","article-title":"Synthetic biotinylated peptide compounds derived from Asp-hemolysin: novel potent inhibitors of platelet-activating factor","volume":"685","author":"Sato","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2016.01.005_bib0220","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1073\/pnas.0436286100","article-title":"Epitope and isotype specificities of antibodies to beta-amyloid peptide for protection against Alzheimer\u2019s disease-like neuropathology","volume":"100","author":"Bard","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2016.01.005_bib0225","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/bc400073z","article-title":"Role of N- or C-terminal biotinylation in autoantibody recognition of citrullin containing filaggrin epitope peptides in rheumatoid arthritis","volume":"24","author":"Babos","year":"2013","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.peptides.2016.01.005_bib0230","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/annrheumdis-2012-202868","article-title":"The fibrin-derived citrullinated peptide \u03b260-74Cit60,72,74 bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies","volume":"73","author":"Cornillet","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.peptides.2016.01.005_bib0235","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jbspin.2007.05.001","article-title":"Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update","volume":"74","author":"Toussirot","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.peptides.2016.01.005_bib0240","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI110127","article-title":"Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis","volume":"67","author":"Alspaugh","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2016.01.005_bib0245","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1073\/pnas.80.23.7104","article-title":"Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide","volume":"80","author":"Billings","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2016.01.005_bib0250","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/ard.47.4.270","article-title":"Reaction of antibodies to rheumatoid arthritis nuclear antigen with a synthetic peptide corresponding to part of Epstein-Barr nuclear antigen 1","volume":"47","author":"Venables","year":"1988","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.peptides.2016.01.005_bib0255","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM198111193052102","article-title":"Defective EBV-specific suppressor T-cell function in rheumatoid arthritis","volume":"305","author":"Tosato","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.peptides.2016.01.005_bib0260","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1172\/JCI111388","article-title":"Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis","volume":"73","author":"Tosato","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2016.01.005_bib0265","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/art.10933","article-title":"Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction","volume":"48","author":"Balandraud","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.peptides.2016.01.005_bib0270","first-page":"866","article-title":"Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis","volume":"27","author":"Blaschke","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.peptides.2016.01.005_bib0275","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/1529-0131(200006)43:6<1218::AID-ANR4>3.0.CO;2-2","article-title":"Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis","volume":"43","author":"Takeda","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.peptides.2016.01.005_bib0280","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/00365510510013857","article-title":"Absence of high-affinity calreticulin autoantibodies in patients with systemic rheumatid diseases and coeliac disease","volume":"65","author":"J\u00f8rgensen","year":"2005","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.peptides.2016.01.005_bib0285","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/jaut.1994.1014","article-title":"Immune response to different sequences of the EBNA1 molecule in Epstein-Barr virus-related disorders and in autoimmune diseases","volume":"7","author":"Marchini","year":"1994","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.peptides.2016.01.005_bib0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144707","article-title":"Contribution of peptide backbone to anti-citrullinated protein antibody reactivity","author":"Trier","year":"2015","journal-title":"PLoS One"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978116300055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978116300055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T19:36:30Z","timestamp":1718307390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978116300055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":58,"alternative-id":["S0196978116300055"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2016.01.005","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of synthetic peptides for detection of anti-citrullinated peptide antibodies","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2016.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}